A year of reorganising and reassessing strategies at Novartis

Leave a Comment / By / September 16, 2025

WTR’s Pharma and Healthcare Team of the Year 2025 explains why it has revisited its prosecution and enforcement strategies.

Post navigation

← Previous

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Type here..

Name*

E-mail*

Website

Save my name, email, and website in this browser for the next time I comment.

Please enter an answer in digits:

15 − 8 =

Este site armazena dados como cookies para habilitar a funcionalidade necessária, incluindo análises, segmentação e personalização. Aviso sobre cookies.

ACEITAR

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

SAVE & ACCEPT